Anika Therapeutics, Inc. (ANIK) Revenue 2016–2025
Anika Therapeutics, Inc. (ANIK) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$112.8MFY2025 · since FY2016: $103.4M → $112.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $112.8M | -5.9% |
| FY2024 | $119.9M | -0.7% |
| FY2023 | $120.8M | +6.1% |
| FY2022 | $113.8M | -23.0% |
| FY2021 | $147.8M | +13.3% |
| FY2020 | $130.5M | +13.8% |
| FY2019 | $114.6M | +8.6% |
| FY2018 | $105.6M | -6.9% |
| FY2017 | $113.4M | +9.7% |
| FY2016 | $103.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice